OCGN
OcugenCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
OCGN vs peer average
51/100
OCGN vs. peer average (C vs. C)
Grade spread
B 4 · C 3 · D 3 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
EPRX is the first available peer comparator.
Eupraxia is a useful small-cap biotech comparison because valuation is also tied to clinical milestones and financing durability rather than established product revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OCGN
Ocugen
EPRX
Eupraxia
Grade
C
B
Momentum
92
20
Value
41
41
Sentiment
40
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs EPRX
OCGN / EPRX
Grade Position
In line
OCGN vs. peer average (C vs. C)
51/100
Momentum
92
OCGNValue
41
OCGNSentiment
40
EPRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OCGN
EPRX is the first peer returned for this comparison set.